Teixobactina e seus análogos: uma revisão sistemática sobre os novos antimicrobianos potentes no combate ao Staphylococcus aureus Meticilina Resistente (MRSA)
Carregando...
Data
Autores
Título da Revista
ISSN da Revista
Título de Volume
Editor
Universidade Federal de Juiz de Fora - Campus Avançado de Governador Valadares
DOI
Resumo
Methicillin-resistant Staphylococcus aureus (MRSA) is an agent of several
serious, potentially fatal human infections that are difficult to treat due to its high
resistance to many antimicrobials used in clinical practice. Therefore, teixobactin, a
new antibiotic with potent action against S. aureus, discovered in 2015, is a target of
analysis due to the possibility of clinical use. The present study aims to evaluate
whether teixobactin and its analogues have relevant activity in combating MRSA. For
this purpose, a systematic review of the literature was conducted in the PubMed,
Embase, SciELO, LILACS and Web of Science databases, with the descriptors and
terms: “teixobactin”, “Staphylococcus aureus”, “methicillin resistant Staphylococcus
aureus” “Elephanteria terrae” and “Staphylococcaceae”. In vitro or in vivo studies with
information on the antimicrobial activity, mechanism of action, cytotoxic effect or
bacterial resistance of the drugs in relation to MRSA or MSSA (methicillin-sensitive S.
aureus) were included. Eighteen articles were selected, in which teixobactin had a
minimum inhibitory concentration (MIC) of approximately 0.25 μg/ml, due to its unique
structure of 4 D-amino acids and an L-allo-endurecidin at position 10. However, due to
the complex and time-consuming synthesis, there was a search for simpler
compounds. The main analogues consisted of substitutions of End10 by positive
charges (arginine, lysine) or neutral charges, such as leucine, with good activity, in a
variable MIC range: <0.0625 to 16 μg/ml. Teixobactin and its analogues also
demonstrated efficacy in combating thigh and intraperitoneal infections in mice and
keratitis in rabbits. This activity is derived from the simultaneous inhibition of the
synthesis of lipids II and III, precursors of peptidoglycan and teichoic acid, respectively.
Bacterial resistance was detected in only one study. These drugs were safe, with low
cytotoxic and hemolytic effects in the cell lines tested. Therefore, teixobactin and its
analogues showed good activity in vitro and in animal models, making them a future
possibility for the treatment of S. aureus infections.
Descrição
Palavras-chave
Teixobactin , Elephanteria terrae , Staphylococcus aureus , Micrococcus aureus , Methicillin resistant staphylococcaceae aureus , Staphylococcusaureus , MRSA , Teixobactin , Elephanteria terrae , Staphylococcus aureus , Micrococcus aureus , Methicillin resistant staphylococcus aureus , MRSA , Staphylococcaceae
Citação
Coleções
Avaliação
Revisão
Suplementado Por
Referenciado Por
Licença Creative Commons
Exceto quando indicado de outra forma, a licença deste item é descrita como Acesso Aberto

